{
    "organizations": [],
    "uuid": "43a4b5bbbb1b4e6126128a4858d5d18a4ba0d727",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-proteon-therapeutics-completes-enr/brief-proteon-therapeutics-completes-enrollment-in-patency-2-phase-3-clinical-trial-of-investigational-vonapanitase-idUSASB0C8VW",
    "ord_in_thread": 0,
    "title": "BRIEF-Proteon Therapeutics Completes Enrollment In Patency-2, Phase 3 Clinical Trial Of Investigational Vonapanitase",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5 (Reuters) - Proteon Therapeutics Inc:\n* PROTEON THERAPEUTICS COMPLETES ENROLLMENT IN PATENCY-2, PHASE 3 CLINICAL TRIAL OF INVESTIGATIONAL VONAPANITASE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-06T07:22:00.000+02:00",
    "crawled": "2018-03-06T22:13:22.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "proteon",
        "therapeutic",
        "inc",
        "proteon",
        "therapeutic",
        "completes",
        "enrollment",
        "phase",
        "clinical",
        "trial",
        "investigational",
        "vonapanitase",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}